#None #Houston #Mann Eye Institute #Dr. Bita Esmaeli #Ophthalmic Oncology

Mann Eye Institute Welcomes Dr. Bita Esmaeli

Mann Eye Institute, a flagship in eye care in Texas, has announced a significant enhancement to its team with the addition of Dr. Bita Esmaeli, a distinguished expert in ophthalmic oncology. This transition is scheduled to become official on October 1, 2025. Dr. Esmaeli’s specialization in treating complex conditions such as orbital tumors and eyelid cancers will greatly expand the institute's already comprehensive offerings.

Founded nearly fifty years ago and operated by veterans, Mann Eye Institute has a long-standing commitment to providing exceptional eye care throughout Texas. With the new addition of Dr. Esmaeli, the practice reinforces its dedication not only to general ophthalmology but also to specialized ophthalmic oncology procedures that require a high level of expertise. Her extensive background in both surgical techniques and patient care dovetails with the institute's mission to treat each individual with the utmost respect and dignity.

Dr. Esmaeli brings more than 26 years of experience, particularly focused on the surgical management of dangerous eyelid and orbital tumors. Until recently, she was a tenured professor at The University of Texas M. D. Anderson Cancer Center, where she made significant contributions as Chief of the Section of Ophthalmology and Director of the Ophthalmic Plastic Surgery Fellowship Program. Her leadership experience and academic involvement significantly enhance her approach to clinical practice.

Her arrival coincides with an increased recognition of the need for specialized care in the treatment of eye cancers, a growing concern among patients and healthcare providers alike. Dr. Esmaeli's accolades speak to her influence within the field; she has received multiple prestigious awards, including the Merrill Reeh Pathology Award from the American Society of Ophthalmic Plastic and Reconstructive Surgery and the Lifetime Achievement Award from the American Academy of Ophthalmology. These achievements underscore her commitment to excellence in patient care, alongside her research contributions to the National Cancer Institute’s Cancer Genome Atlas project.

In a statement reflecting her enthusiasm for joining the Mann Eye Institute, Dr. Esmaeli expressed her eagerness to continue making strides in ophthalmic oncology treatments, emphasizing a commitment to high-quality care that prioritizes patient needs.